Highest development stage: Phase 3 (NCT05857163)

Development status: Active (as of 2023)

Gram-positive activity

Gram-negative activity

Mechanism of Action/Target pathogen: Active against <i>Helicobacter pylori</i> and <i>Clostridioides difficile</i>

Additional information: Synthetic compound